203 related articles for article (PubMed ID: 8213063)
1. T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Frequin ST; Lamers KJ; Borm GF; Barkhof F; Jongen PJ; Hommes OR
Acta Neurol Scand; 1993 Aug; 88(2):80-6. PubMed ID: 8213063
[TBL] [Abstract][Full Text] [Related]
2. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
Frequin ST; Barkhof F; Lamers KJ; Hommes OR; Borm GF
Acta Neurol Scand; 1992 Sep; 86(3):291-7. PubMed ID: 1384263
[TBL] [Abstract][Full Text] [Related]
3. Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis.
Wang HY; Matsui M; Araya S; Onai N; Matsushima K; Saida T
J Neurol Sci; 2003 Dec; 216(1):61-6. PubMed ID: 14607304
[TBL] [Abstract][Full Text] [Related]
4. High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients.
Dufour A; Salmaggi A; La Mantia L; Eoli M; Nespolo A; Milanese C
Int J Neurosci; 1994 Mar; 75(1-2):119-28. PubMed ID: 7914185
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
6. T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients.
Scolozzi R; Boccafogli A; Tola MR; Vicentini L; Camerani A; Degani D; Granieri E; Caniatti L; Paolino E
J Neurol Sci; 1992 Mar; 108(1):93-8. PubMed ID: 1352538
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood cell immunomarkers in the course of methylprednisolone treatment of multiple sclerosis relapses.
Michałowska-Wender G; Wender M
Folia Neuropathol; 2008; 46(2):134-8. PubMed ID: 18587707
[TBL] [Abstract][Full Text] [Related]
8. T-cell subsets in multiple sclerosis: relationships between peripheral blood and cerebrospinal fluid.
Zaffaroni M; Caputo D; Ghezzi A; Cazzullo CL
Acta Neurol Scand; 1985 Mar; 71(3):242-8. PubMed ID: 3873164
[TBL] [Abstract][Full Text] [Related]
9. The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment.
Luján S; Masjuan J; Roldán E; Villar LM; González-Porqué P; Alvarez-Cermeño JC
Mult Scler; 1998 Jun; 4(3):239-42. PubMed ID: 9762681
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone.
Franciotta D; Piccolo G; Zardini E; Bergamaschi R; Cosi V
Acta Neurol Scand; 1997 May; 95(5):275-9. PubMed ID: 9188901
[TBL] [Abstract][Full Text] [Related]
11. T-cell subpopulations in blood and cerebrospinal fluid of multiple sclerosis patients: effect of cyclophosphamide.
Brinkman CJ; Nillesen WM; Hommes OR
Clin Immunol Immunopathol; 1983 Dec; 29(3):341-8. PubMed ID: 6605824
[TBL] [Abstract][Full Text] [Related]
12. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
[TBL] [Abstract][Full Text] [Related]
13. Follow-up study of MS patients treated with high-dose intravenous methylprednisolone.
Frequin ST; Lamers KJ; Barkhof F; Borm GF; Hommes OR
Acta Neurol Scand; 1994 Aug; 90(2):105-10. PubMed ID: 7801735
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
Wurth S; Kuenz B; Bsteh G; Ehling R; Di Pauli F; Hegen H; Auer M; Gredler V; Deisenhammer F; Reindl M; Berger T
PLoS One; 2017; 12(8):e0182462. PubMed ID: 28777826
[TBL] [Abstract][Full Text] [Related]
15. Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone.
Frequin ST; Wevers RA; Braam M; Barkhof F; Hommes OR
J Neurol; 1993 May; 240(5):305-8. PubMed ID: 8326337
[TBL] [Abstract][Full Text] [Related]
16. High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
Harrer A; Pilz G; Wipfler P; Oppermann K; Sellner J; Hitzl W; Haschke-Becher E; Afazel S; Rispens T; van der Kleij D; Trinka E; Kraus J
Clin Exp Immunol; 2015 Jun; 180(3):383-92. PubMed ID: 25603898
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse.
Hecker M; Fitzner B; Koczan D; Klehmet J; Grothe M; Schwab M; Winkelmann A; Meister S; Dudesek A; Ludwig-Portugall I; Eulitz K; Zettl UK
Biomed Pharmacother; 2024 Jun; 175():116721. PubMed ID: 38749180
[TBL] [Abstract][Full Text] [Related]
18. Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.
Martínez-Cáceres EM; Barrau MA; Brieva L; Espejo C; Barberà N; Montalban X
Clin Exp Immunol; 2002 Jan; 127(1):165-71. PubMed ID: 11882048
[TBL] [Abstract][Full Text] [Related]
19. [Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone].
Yagi Y; Takahashi M; Nakamura Y
Rinsho Shinkeigaku; 1997 Jul; 37(7):575-9. PubMed ID: 9396353
[TBL] [Abstract][Full Text] [Related]
20. Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.
Kraus J; Oschmann P; Engelhardt B; Bauer R; Schiel C; Kern A; Stolz E; Traupe A; Dorndorf W
Acta Neurol Scand; 2000 Feb; 101(2):135-9. PubMed ID: 10685862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
